American Journal of Ophthalmology
Volume 137, Issue 2 , Pages 236-243 , February 2004

Liver function tests in metastatic uveal melanoma

  • Igor Kaiserman, MD, MSc, MPA

      Affiliations

    • Department of Ophthalmology, Hadassah University Hospital, Jerusalem, Israel
    • Corresponding Author InformationInquiries to Igor Kaiserman, MD, MSc, MPA, Department of Ophthalmology, Hadassah University Hospital, P.O.B. 12000, IL-91120 Jerusalem, Israel; fax: (+972) 26416242
    • ,
  • Radgonde Amer, MD

      Affiliations

    • Department of Ophthalmology, Hadassah University Hospital, Jerusalem, Israel
    • ,
  • Jacob Pe'er, MD

      Affiliations

    • Department of Ophthalmology, Hadassah University Hospital, Jerusalem, Israel

,Accepted 14 August 2003.

References 

  1. Mooy CM, De Jong PT. Prognostic parameters in uveal melanoma (A review). Surv Ophthalmol. 1996;41:215–228
  2. Diener West M, Earle JD, Fine SL, et al.  The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III (initial mortality findings. COMS Report No 18). Arch Ophthalmol. 2001;119:969–982
  3. McLean IW, Foster WD, Zimmerman LE. Uveal melanoma (Location, size, cell type, and enucleation as risk factors in metastasis). Hum Pathol. 1982;13:123–132
  4. Singh AD, Shields CL, Shields JA. Prognostic factors in uveal melanoma. Melanoma Res. 2001;11:255–263
  5. Leyvraz S, Spataro V, Bauer J, et al.  Treatment of ocular melanoma metastatic to the liver by hepatic arterial chemotherapy. J Clin Oncol. 1997;15:2589–2595
  6. Einhorn LH, Burgess MA, Gottlieb JA. Metastatic patterns of choroidal melanoma. Cancer. 1974;34:1001–1004
  7. Zakka KA, Foos RY, Omphroy CA, Straatsma BR. Malignant melanoma (Analysis of an autopsy population). Ophthalmology. 1980;87:549–556
  8. Donoso LA, Berd D, Augsburger JJ, et al.  Metastatic uveal melanoma (Pretherapy serum liver enzyme and liver scan abnormalities). Arch Ophthalmol. 1985;103:796–798
  9. Hicks C, Foss AJ, Hungerford JL. Predictive power of screening tests for metastasis in uveal melanoma. Eye. 1998;12:945–948
  10. Eskelin S, Pyrhonen S, Summanen P, et al.  Screening for metastatic malignant melanoma of the uvea revisited. Cancer. 1999;85:1151–1159
  11. Char DH. Metastatic choroidal melanoma. Am J Ophthalmol. 1978;86:76–80
  12. Sutherland CM, Chmiel JS, Haik BG, et al.  Patient characteristics, methods of evaluation and treatment of ocular melanoma in the United States for the years 1981 and 1987. Surg Gynecol Obstet. 1993;177:497–503
  13. Collaborative Ocular Melanoma Study Group . Design and methods of a clinical trial for a rare condition (The Collaborative Ocular Melanoma Study. COMS Report No. 3). Control Clin Trials. 1993;14:362–391
  14. Aoyama T, Mastrangelo MJ, Berd D, et al.  Protracted survival after resection of metastatic uveal melanoma. Cancer. 2000;89:1561–1568
  15. Woll E, Bedikian A, Legha SS. Uveal melanoma (Natural history and treatment options for metastatic disease). Melanoma Res. 1999;9:575–581
  16. Egerer G, Lehnert T, Max R, et al.  Pilot study of hepatic intraarterial fotemustine chemotherapy for liver metastases from uveal melanoma (A single-center experience with seven patients). Int J Clin Oncol. 2001;6:25–28

☆ Biosketches and/or additional material at www.ajo.com. doi:10.1016/j.ajo.2003.08.045Internet Advance publication at ajo.com August 28, 2003

PII: S0002-9394(03)01008-0

doi: 10.1016/j.ajo.2003.08.045

American Journal of Ophthalmology
Volume 137, Issue 2 , Pages 236-243 , February 2004

Article Tools

* Image Usage & Resolution